Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial.
Valderrábano M, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, DeLurgio D, Athill CA, Ellenbogen KA, Natale A, Koneru J, Dave AS, Giorgberidze I, Afshar H, Guthrie ML, Bunge R, Morillo CA, Kleiman NS. Valderrábano M, et al. Among authors: delurgio d. JAMA. 2020 Oct 27;324(16):1620-1628. doi: 10.1001/jama.2020.16195. JAMA. 2020. PMID: 33107945 Free PMC article. Clinical Trial.
Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, Shinn T, Dan D, Feldman LA, Seide H, Winston SA, Gallagher JJ, Langberg JJ, Mitchell K, Holcomb R; REPLACE Registry Investigators. Poole JE, et al. Circulation. 2010 Oct 19;122(16):1553-61. doi: 10.1161/CIRCULATIONAHA.110.976076. Epub 2010 Oct 4. Circulation. 2010. PMID: 20921437
Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA. Kron J, et al. Among authors: delurgio db. Europace. 2013 Mar;15(3):347-54. doi: 10.1093/europace/eus316. Epub 2012 Sep 21. Europace. 2013. PMID: 23002195
Phased RF ablation in persistent atrial fibrillation.
Hummel J, Michaud G, Hoyt R, DeLurgio D, Rasekh A, Kusumoto F, Giudici M, Dan D, Tschopp D, Calkins H, Boersma L; TTOP-AF Investigators. Hummel J, et al. Among authors: delurgio d. Heart Rhythm. 2014 Feb;11(2):202-9. doi: 10.1016/j.hrthm.2013.11.009. Epub 2013 Nov 14. Heart Rhythm. 2014. PMID: 24239841 Clinical Trial.
Venous Vascular Closure System Versus Manual Compression Following Multiple Access Electrophysiology Procedures: The AMBULATE Trial.
Natale A, Mohanty S, Liu PY, Mittal S, Al-Ahmad A, De Lurgio DB, Horton R, Spear W, Bailey S, Bunch J, Musat D, O'Neill P, Compton S, Turakhia MP; AMBULATE Trial Investigators. Natale A, et al. JACC Clin Electrophysiol. 2020 Jan;6(1):111-124. doi: 10.1016/j.jacep.2019.08.013. Epub 2019 Oct 30. JACC Clin Electrophysiol. 2020. PMID: 31971899 Free article. Clinical Trial.
Outcomes of convergent atrial fibrillation ablation with continuous rhythm monitoring.
Larson J, Merchant FM, Patel A, Ndubisi NM, Patel AM, DeLurgio DB, Lloyd MS, El-Chami MF, Leon AR, Hoskins MH, Keeling WB, Halkos ME, Lattouf OM, Westerman S. Larson J, et al. J Cardiovasc Electrophysiol. 2020 Jun;31(6):1270-1276. doi: 10.1111/jce.14454. Epub 2020 Apr 6. J Cardiovasc Electrophysiol. 2020. PMID: 32219901
Evaluation of stroke incidence with duty-cycled multielectrode-phased radiofrequency ablation of persistent atrial fibrillation results of the VICTORY AF Study.
Hummel J, Verma A, Calkins H, Schwamm LH, Gress D, Wells D, Souza J, Hokanson RB, Hemingway L, Stromberg K, Hoyt R, Wickliffe A, DeLurgio D, Boersma L. Hummel J, et al. Among authors: delurgio d. J Cardiovasc Electrophysiol. 2020 Jun;31(6):1289-1297. doi: 10.1111/jce.14483. Epub 2020 Apr 24. J Cardiovasc Electrophysiol. 2020. PMID: 32270538 Clinical Trial.
Results from the prospective, multicenter AMBULATE-CAP trial: Reduced use of urinary catheters and protamine with hemostasis via the Mid-Bore Venous Vascular Closure System (VASCADE® MVP) following multi-access cardiac ablation procedures.
Al-Ahmad A, Mittal S, DeLurgio D, Joseph Gallinghouse G, Horton RP, Preminger MW, David Burkhardt J, Natale A. Al-Ahmad A, et al. Among authors: delurgio d. J Cardiovasc Electrophysiol. 2021 Feb;32(2):191-199. doi: 10.1111/jce.14828. Epub 2020 Dec 14. J Cardiovasc Electrophysiol. 2021. PMID: 33270306 Clinical Trial.
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial.
Lador A, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, DeLurgio D, Athill CA, Ellenbogen KA, Natale A, Koneru J, Dave AS, Giorgberidze I, Afshar H, Guthrie ML, Bunge R, Morillo CA, Kleiman NS, Valderrábano M. Lador A, et al. Among authors: delurgio d. Heart Rhythm. 2021 Jul;18(7):1045-1054. doi: 10.1016/j.hrthm.2021.01.005. Epub 2021 Jan 19. Heart Rhythm. 2021. PMID: 33482387 Free PMC article. Clinical Trial.
103 results